新生儿败血症使用敏感抗生素治疗的疗效与安全性研究

Key Points

• The study aims to evaluate the clinical efficacy and safety of using sensitive antibiotics to treat neonatal sepsis.
• Randomized controlled trial involving 120 neonates with sepsis from January 2020 to January 2024.
• Participants were divided into an observation group receiving sensitive antibiotics and a control group receiving empirical antibiotics.
• Comparative analysis of clinical efficacy, bacterial clearance rates, and incidence of adverse reactions between groups.
• The observation group showed a significantly higher total effective rate compared to the control group.
• Bacterial clearance rate was better in the observation group than in the control group.
• The incidence of adverse reactions was lower in the observation group, with statistically significant differences (P < 0.05).